Financial Ratios

PANJON LTD.

NSE : NABSE : 526345ISIN CODE : INE744D01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE18.83-0.21 (-1.1 %)
PREV CLOSE ( ) 19.04
OPEN PRICE ( ) 19.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1965
TODAY'S LOW / HIGH ( )18.60 19.50
52 WK LOW / HIGH ( ) 11.921.79
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.52-2.680.06-0.020.09
   CEPS(Rs)0.66-2.550.210.160.19
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)8.708.1710.8510.7910.82
   Tax Rate(%)-587.56-3.4250.00117.1750.59
Margin Ratios
   Core EBITDA Margin(%)-0.09-47.951.311.221.03
   EBIT Margin(%)2.73-46.832.011.281.85
   Pre Tax Margin(%)1.93-47.611.320.711.09
   PAT Margin (%)13.30-49.240.66-0.120.54
   Cash Profit Margin (%)16.76-46.832.210.911.12
Performance Ratios
   ROA(%)5.94-25.770.52-0.180.78
   ROE(%)6.20-28.170.57-0.190.84
   ROCE(%)1.20-24.991.601.842.59
   Asset Turnover(x)0.450.520.781.441.44
   Sales/Fixed Asset(x)0.771.091.913.603.75
   Working Capital/Sales(x)0.641.081.362.563.05
Efficiency Ratios
   Fixed Capital/Sales(x)1.300.920.520.280.27
   Receivable days64.8093.3587.9934.4418.39
   Inventory Days217.32165.5096.4251.3349.08
   Payable days85.8356.7426.957.842.95
Valuation Parameters
   PER(x)22.330.000.000.000.00
   PCE(x)17.71-6.910.000.000.00
   Price/Book(x)1.342.150.000.000.00
   Yield(%)0.000.00
   EV/Net Sales(x)2.863.161.140.630.65
   EV/Core EBITDA(x)46.14-7.1131.9127.4426.70
   EV/EBIT(x)104.73-6.7556.5349.5335.00
   EV/CE(x)1.271.960.890.910.93
   M Cap / Sales2.973.230.000.000.00
Growth Ratio
   Net Sales Growth(%)-27.76-42.00-44.981.8829.06
   Core EBITDA Growth(%)110.07-824.09-15.40-2.9932.63
   EBIT Growth(%)104.21-1452.16-13.79-29.5630.69
   PAT Growth(%)119.51-4413.53399.49-122.9713.82
   EPS Growth(%)119.51-4413.53399.48-122.9713.82
Financial Stability Ratios
   Total Debt/Equity(x)0.060.060.080.090.11
   Current Ratio(x)9.178.238.829.7710.38
   Quick Ratio(x)6.174.755.986.536.39
   Interest Cover(x)3.44-60.322.932.242.43
   Total Debt/Mcap(x)0.040.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.